Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 27 M26 M26 M26 M27 M26 M 105 M Research & development —————— — Operating income 826 M715 M696 M1.47 B361 M1.34 B 3.87 B Non-Operating Income, Total -185 M-162 M-190 M-182 M-175 M-179 M -726 M Interest expense, net of interest capitalized 190 M188 M189 M186 M181 M183 M 739 M Non-Operating Income, excl. Interest Expenses -185 M-184 M-380 M-365 M-357 M-366 M -1.47 B Unusual income/expense 022 M1 M-3 M1 M4 M 3 M Pretax income 451 M365 M317 M1.1 B5 M978 M 2.4 B Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense -4 M-5 M-10 M-7 M-5 M-3 M -25 M Net income before discontinued operations 641 M553 M506 M1.29 B186 M1.16 B 3.14 B Discontinued operations —————— — Net income 641 M553 M506 M1.29 B186 M1.16 B 3.14 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 511 M511 M520 M520 M482 M511 M 2.03 B Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 997 M886 M869 M1.64 B535 M1.51 B 4.56 B EBIT 826 M715 M696 M1.47 B361 M1.34 B 3.87 B Cost of revenue 1.7 B1.2 B1.28 B968 M2.76 B765 M 5.77 B Other cost of goods sold 1.7 B1.2 B1.28 B968 M2.76 B765 M 5.77 B Depreciation & amortization (cash flow) 171 M171 M173 M173 M174 M174 M 694 M